BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23469018)

  • 1. In human monocyte derived dendritic cells SOCS1 interacting with CYTIP induces the degradation of CYTIP by the proteasome.
    Grabher D; Hofer S; Ortner D; Heufler C
    PLoS One; 2013; 8(2):e57538. PubMed ID: 23469018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cell maturation stage determines susceptibility to the proteasome inhibitor bortezomib.
    Subklewe M; Sebelin-Wulf K; Beier C; Lietz A; Mathas S; Dörken B; Pezzutto A
    Hum Immunol; 2007 Mar; 68(3):147-55. PubMed ID: 17349869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection of dendritic cells with herpes simplex virus type 1 induces rapid degradation of CYTIP, thereby modulating adhesion and migration.
    Theodoridis AA; Eich C; Figdor CG; Steinkasserer A
    Blood; 2011 Jul; 118(1):107-15. PubMed ID: 21562043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute alcohol intake induces SOCS1 and SOCS3 and inhibits cytokine-induced STAT1 and STAT3 signaling in human monocytes.
    Norkina O; Dolganiuc A; Catalano D; Kodys K; Mandrekar P; Syed A; Efros M; Szabo G
    Alcohol Clin Exp Res; 2008 Sep; 32(9):1565-73. PubMed ID: 18616672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressor of Cytokine Signaling (SOCS)1 Regulates Interleukin-4 (IL-4)-activated Insulin Receptor Substrate (IRS)-2 Tyrosine Phosphorylation in Monocytes and Macrophages via the Proteasome.
    McCormick SM; Gowda N; Fang JX; Heller NM
    J Biol Chem; 2016 Sep; 291(39):20574-87. PubMed ID: 27507812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDA-7/IL-24, a novel tumor suppressor/cytokine is ubiquitinated and regulated by the ubiquitin-proteasome system, and inhibition of MDA-7/IL-24 degradation enhances the antitumor activity.
    Gopalan B; Shanker M; Scott A; Branch CD; Chada S; Ramesh R
    Cancer Gene Ther; 2008 Jan; 15(1):1-8. PubMed ID: 17828282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective apoptosis of monocytes and monocyte-derived DCs induced by bortezomib (Velcade).
    Arpinati M; Chirumbolo G; Nicolini B; Agostinelli C; Rondelli D
    Bone Marrow Transplant; 2009 Feb; 43(3):253-9. PubMed ID: 18806836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressor of cytokine signaling (SOCS) proteins are induced by IL-7 and target surface CD127 protein for degradation in human CD8 T cells.
    Ghazawi FM; Faller EM; Parmar P; El-Salfiti A; MacPherson PA
    Cell Immunol; 2016; 306-307():41-52. PubMed ID: 27423467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteasomal chymotrypsin-like peptidase activity is required for essential functions of human monocyte-derived dendritic cells.
    Naujokat C; Berges C; Höh A; Wieczorek H; Fuchs D; Ovens J; Miltz M; Sadeghi M; Opelz G; Daniel V
    Immunology; 2007 Jan; 120(1):120-32. PubMed ID: 17083604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteasome inhibitor bortezomib modulates TLR4-induced dendritic cell activation.
    Nencioni A; Schwarzenberg K; Brauer KM; Schmidt SM; Ballestrero A; Grünebach F; Brossart P
    Blood; 2006 Jul; 108(2):551-8. PubMed ID: 16537813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cell maturation requires STAT1 and is under feedback regulation by suppressors of cytokine signaling.
    Jackson SH; Yu CR; Mahdi RM; Ebong S; Egwuagu CE
    J Immunol; 2004 Feb; 172(4):2307-15. PubMed ID: 14764699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressor of cytokine signaling 2 is a feedback inhibitor of TLR-induced activation in human monocyte-derived dendritic cells.
    Posselt G; Schwarz H; Duschl A; Horejs-Hoeck J
    J Immunol; 2011 Sep; 187(6):2875-84. PubMed ID: 21844389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking autophagy prevents bortezomib-induced NF-κB activation by reducing I-κBα degradation in lymphoma cells.
    Jia L; Gopinathan G; Sukumar JT; Gribben JG
    PLoS One; 2012; 7(2):e32584. PubMed ID: 22393418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinase inhibition, competitive binding and proteasomal degradation: resolving the molecular function of the suppressor of cytokine signaling (SOCS) proteins.
    Linossi EM; Nicholson SE
    Immunol Rev; 2015 Jul; 266(1):123-33. PubMed ID: 26085211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of cell adhesion in lymphocytes is regulated by CYTIP, a protein which mediates signal complex sequestration.
    Boehm T; Hofer S; Winklehner P; Kellersch B; Geiger C; Trockenbacher A; Neyer S; Fiegl H; Ebner S; Ivarsson L; Schneider R; Kremmer E; Heufler C; Kolanus W
    EMBO J; 2003 Mar; 22(5):1014-24. PubMed ID: 12606567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the cytokine-inducible SH2 protein CIS in desensitization of STAT5b signaling by continuous growth hormone.
    Ram PA; Waxman DJ
    J Biol Chem; 2000 Dec; 275(50):39487-96. PubMed ID: 10991939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cells regulate T-cell deattachment through the integrin-interacting protein CYTIP.
    Hofer S; Pfeil K; Niederegger H; Ebner S; Nguyen VA; Kremmer E; Auffinger M; Neyer S; Fürhapter C; Heufler C
    Blood; 2006 Feb; 107(3):1003-9. PubMed ID: 16204317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The E3 ubiquitin ligase HOIL-1 induces the polyubiquitination and degradation of SOCS6 associated proteins.
    Bayle J; Lopez S; Iwaï K; Dubreuil P; De Sepulveda P
    FEBS Lett; 2006 May; 580(11):2609-14. PubMed ID: 16643902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of bortezomib-adapted I-45 mesothelioma cells.
    Zhang L; Littlejohn JE; Cui Y; Cao X; Peddaboina C; Smythe WR
    Mol Cancer; 2010 May; 9():110. PubMed ID: 20482802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic effects of bortezomib in myelodysplastic syndrome/acute myeloid leukemia depend on autophagy-mediated lysosomal degradation of TRAF6 and repression of PSMA1.
    Fang J; Rhyasen G; Bolanos L; Rasch C; Varney M; Wunderlich M; Goyama S; Jansen G; Cloos J; Rigolino C; Cortelezzi A; Mulloy JC; Oliva EN; Cuzzola M; Starczynowski DT
    Blood; 2012 Jul; 120(4):858-67. PubMed ID: 22685174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.